Cian Healthcare Peer Comparison

Cian Healthcare Ltd. shows significant potential for growth despite current challenges, particularly in EPS growth, while being overshadowed by peers in profitability and valuation metrics. It presents a unique investment opportunity for those willing to take on higher risk for possible future returns.

• • Cian Healthcare Ltd. has impressive EPS growth of 64.85% over three years, indicating strong potential despite current revenue decline.
• • The company has the lowest PBV at 0.2052, making it a potential deep value pick for investors.
• • High debt levels (1.4021) relative to peers could pose risks, but efficient cash flow metrics suggest operational viability.

• • Mankind Pharma Ltd.: Highest revenue growth YoY (18.12%) and strong profitability with high ROE (23.15%) and low debt (0.021).
• • Dr. Reddy's Laboratories Ltd.: Strong profitability metrics with high ROE (21.76%) and attractive valuation (PE of 15.50).